Related Experiment Video
Updated: Jan 2, 2026

07:04
Virtual Reality Tools for Assessing Unilateral Spatial Neglect: A Novel Opportunity for Data Collection
Published on: March 10, 2021
4.4K
Validation of a Head-mounted Virtual Reality Visual Field Screening Device.
Lukas Mees1, Swati Upadhyaya2, Pavan Kumar2
1Johns Hopkins University, Baltimore, MD.
Journal of Glaucoma
|December 3, 2019
Summary
The C3 Fields Analyzer (CFA) shows moderate reliability for glaucoma detection, preferred by patients over standard perimetry. While not a perfect match for the Humphrey Visual Field Analyzer, it effectively identifies glaucoma subjects.
Area of Science:
- Ophthalmology
- Medical Technology
- Glaucoma Research
Background:
- Visual field testing is crucial for glaucoma diagnosis and management.
- The Humphrey Visual Field Analyzer (HFA) is the current standard but is large, costly, and can be uncomfortable.
- The C3 Fields Analyzer (CFA) is a novel virtual reality head-mounted device for visual field testing.
Purpose of the Study:
- To investigate the efficacy of the CFA as a subjective visual field test for glaucoma screening and monitoring.
- To compare the performance of the CFA with the established HFA.
Main Methods:
- The CFA presented stimuli in 54 positions, mirroring the HFA 24-2 SITA Standard test.
- A suprathreshold algorithm approximating an 18 dB deficit was used.
- 157 patients (controls and glaucoma patients) were tested with both the CFA and HFA.
Main Results:
- Missed stimuli on the CFA correlated with HFA mean deviation (r=0.62) and pattern standard deviation (r=0.36).
- The area under the ROC curve was 0.77 for mild glaucoma and 0.86 for moderate-advanced glaucoma.
- 38% of patients with an 18 dB or worse deficit on HFA missed the CFA stimulus at the same location.
Conclusions:
- The CFA demonstrated moderate effectiveness in identifying glaucoma subjects.
- The device did not reliably replicate point-by-point deficits identified by the HFA.
- Further device refinements are necessary to enhance testing and screening performance.

